[MHC tetramers: tracking specific immunity].

Area of Science:

• Immunology
• Cellular Biology
• Molecular Medicine

Context:

• Adaptive immunity relies on T cells for infection control, anti-tumor effects, and autoimmune disease pathology.
• T cell specificity is determined by T cell receptors (TCRs), necessitating direct measurement of antigen-specific T lymphocytes for understanding immune responses.
• Major histocompatibility complex (MHC) class I and II molecules present antigens to CD8+ cytotoxic and CD4+ T helper cells, respectively.

Purpose:

• To describe the utility of MHC tetramer technology for quantifying antigen-specific T cells ex vivo.
• To highlight the application of tetramer technology combined with intracellular cytokine staining for comprehensive T cell analysis.
• To explore the insights gained from MHC tetramer technology in various disease contexts and its potential for immunotherapy.

Summary:

• MHC tetramer technology allows for the quantification of antigen-specific T cells by binding soluble MHC-peptide complexes to fluorochromes.
• This technique, with high sensitivity, enables detailed analysis of T cell life cycle, effector functions, and dynamics in vivo.
• MHC tetramers have provided valuable data on CD8+ T cell function in viral infections, cancer, autoimmune diseases, and transplantation.

Impact:

• Provides critical information for monitoring immune responses and developing diagnostic tools for T cell-mediated immunity.
• Offers potential for novel vaccination strategies and cell-based therapies, including immunotherapy for cancer and viral infections.
• Facilitates targeted immunotherapy for autoimmune diseases and prevention of organ transplant rejection, though further research is needed.